Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials

by   Nima S. Hejazi, et al.

The advent and subsequent widespread availability of preventive vaccines has altered the course of public health over the past century. Despite this success, effective vaccines to prevent many high-burden diseases, including HIV, have been slow to develop. Vaccine development can be aided by the identification of immune response markers that serve as effective surrogates for clinically significant infection or disease endpoints. However, measuring immune response is often costly, which has motivated the usage of two-phase sampling for immune response sampling in clinical trials of preventive vaccines. In such trials, measurement of immunological markers is performed on a subset of trial participants, where enrollment in this second phase is potentially contingent on the observed study outcome and other participant-level information. We propose nonparametric methodology for efficiently estimating a counterfactual parameter that quantifies the impact of a given immune response marker on the subsequent probability of infection. Along the way, we fill in a theoretical gap pertaining to the asymptotic behavior of nonparametric efficient estimators in the context of two-phase sampling, including a multiple robustness property enjoyed by our estimators. Techniques for constructing confidence intervals and hypothesis tests are presented, and an open source software implementation of the methodology, the txshift R package, is introduced. We illustrate the proposed techniques using data from a recent preventive HIV vaccine efficacy trial.


page 1

page 2

page 3

page 4


Identified vaccine efficacy for binary post-infection outcomes under misclassification without monotonicity

In order to meet regulatory approval, pharmaceutical companies often mus...

Ongoing Vaccine and Monoclonal Antibody HIV Prevention Efficacy Trials and Considerations for Sequel Efficacy Trial Designs

Four randomized placebo-controlled efficacy trials of a candidate vaccin...

Improved inference for vaccine-induced immune responses via shape-constrained methods

We study the performance of shape-constrained methods for evaluating imm...

Low incidence rate of COVID-19 undermines confidence in estimation of the vaccine efficacy

Knowing the true effect size of clinical interventions in randomised cli...

Analyzing Basket Trials under Multisource Exchangeability Assumptions

Basket designs are prospective clinical trials that are devised with the...

Post-randomization Biomarker Effect Modification in an HIV Vaccine Clinical Trial

While the HVTN 505 trial showed no overall efficacy of the tested vaccin...

Please sign up or login with your details

Forgot password? Click here to reset